Range Low Price High Price Comment
30 days $14.90 $17.25 Wednesday, 1st May 2024 VRNA stock ended at $15.22. This is 1.49% less than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 3.49% from a day low at $15.20 to a day high of $15.73.
90 days $14.90 $19.10
52 weeks $11.83 $23.81

Historical Verona Pharma plc prices

Date Open High Low Close Volume
Feb 20, 2024 $17.23 $17.58 $16.85 $17.00 342 707
Feb 16, 2024 $16.75 $17.22 $16.57 $17.20 439 932
Feb 15, 2024 $17.57 $17.60 $16.63 $16.75 934 159
Feb 14, 2024 $17.32 $17.67 $16.98 $17.45 525 828
Feb 13, 2024 $17.00 $17.71 $16.80 $16.96 570 147
Feb 12, 2024 $17.00 $17.39 $17.00 $17.20 401 086
Feb 09, 2024 $16.48 $17.08 $16.39 $17.01 468 704
Feb 08, 2024 $16.26 $16.51 $15.55 $16.28 568 342
Feb 07, 2024 $17.20 $17.23 $16.30 $16.34 528 038
Feb 06, 2024 $17.44 $18.07 $17.00 $17.19 541 858
Feb 05, 2024 $18.06 $18.06 $17.46 $17.57 302 390
Feb 02, 2024 $18.39 $18.39 $17.37 $18.31 453 500
Feb 01, 2024 $18.80 $19.10 $18.47 $18.52 328 548
Jan 31, 2024 $18.41 $19.27 $18.35 $18.35 404 561
Jan 30, 2024 $19.09 $19.09 $18.22 $18.40 434 563
Jan 29, 2024 $17.96 $19.17 $17.81 $19.07 304 806
Jan 26, 2024 $17.88 $18.18 $17.69 $17.89 240 250
Jan 25, 2024 $17.28 $17.92 $17.00 $17.88 282 234
Jan 24, 2024 $17.31 $17.43 $16.95 $16.99 346 716
Jan 23, 2024 $17.19 $17.62 $16.82 $17.04 717 749
Jan 22, 2024 $16.90 $17.27 $16.52 $17.13 656 743
Jan 19, 2024 $17.22 $17.87 $16.95 $17.17 415 566
Jan 18, 2024 $17.33 $17.45 $16.88 $17.18 461 433
Jan 17, 2024 $17.27 $17.40 $17.05 $17.24 519 158
Jan 16, 2024 $17.67 $18.05 $17.39 $17.42 519 149
Click to get the best stock tips daily for free!

About Verona Pharma plc

Verona Pharma plc Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the ... VRNA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT